RKLB Pulls Back 9% From Its $130 ATH As the 69% Week Cools Off
After a five-session, 69% run that stacked the May 7 Q1 beat, the Cowen-to-$120 upgrade wave, the Mynaric AG close, and a clean Neutron stage separation test into a single repricing, RKLB ran out of new news. Cash RKLB tagged a fresh $130.37 intraday all-time high before fading back into the low-$123s, and the xyz:RKLB perp followed it down for a 9.04% 24h move. At roughly 108x trailing sales versus a 14.6 five-year average, on no specific bad headline, this prints as profit-taking rather than a thesis change.
Mover Brief
Profit-Taking, Not News
Over the five sessions ending today, RKLB ran roughly 69% — from sub-$80 into a fresh $130.37 intraday all-time high — on the back of a stacked set of catalysts. The May 7 Q1 print delivered $200.3M in revenue against a $189.7M consensus, a $2.2B backlog up triple digits year over year, and Q2 guidance of $225M to $240M well above the street. Within a week, Cowen took its target to a street-high $120, with Cantor walking theirs to $96 and Stifel to $110. The Mynaric AG acquisition closed, the Motiv Space Systems deal was announced, and Neutron cleared its full-flight-load stage separation test campaign. Today, with the tape sitting on an ATH and the calendar empty, RKLB gave back 9% over 24 hours on no specific negative catalyst. That is what a classic profit-taking pullback after a 69% week looks like — the news that drove the move is already in the price, and the marginal buyer is no longer chasing.
108x Sales Is the Tax
What this prints into is a valuation north of 108x trailing sales versus a five-year average closer to 14.6. The fundamentals underneath are real — 63% revenue growth, a backlog that more than doubled year over year, a Neutron program clearing engineering gates, and a Space Systems mix shift that is starting to look like the dominant line of the business. But Rocket Lab is still loss-making, with a FY2025 net loss of $198M and a Q1 2026 operating loss of $56M, and at 108x sales the multiple is the most fragile thing on the screen. Days like today are how the market reminds itself of that. The growth thesis stays intact; the entry price is the entire question — and at $130 the tape was answering it with a yes that had no margin for error.
The Level That Matters
The xyz:RKLB perp at $123.10 has slipped back into the breakout zone from May 11, when cash RKLB tagged a $122.93 intraday high before the stacked-catalyst week truly opened up. That zone is now the swing line for the entire move. Hold it and the higher-low structure stays intact, and the new bid reads this pullback as continuation rather than distribution. Lose it and a non-trivial slice of last week's chasers — anyone who paid up between $125 and $130 — is suddenly underwater, and the gap-fill back toward the early-May base near $100 starts to gain weight. The HIP-3 perp's $4.69M 24h notional is thin enough that whichever side of $122.93 closes the next session likely picks the next leg.
Sources
- Motley Fool — Why Rocket Lab Stock Is Rocketing Higher This Week
- Trefis — Rocket Lab Stock Rockets 69% With 5-Day Winning Streak
- MarketBeat — Rocket Lab Reaches New 1-Year High, What's Next
- Quiver Quantitative — RKLB Q1 Earnings Beat and Contract Wins+Opinions+on+Q1+Earnings+Beat+and+Contract+Wins)
- TheStreet — Veteran analyst doubles down on Rocket Lab after earnings
*This content is for informational purposes only and does not constitute financial advice. Trading perpetual futures involves substantial risk of loss.*
Trade RKLB on Hyperliquid
Use referral code HIPERWIRE for 4% off trading fees on your first $25M in volume.
Live Market Metrics
Monitor real-time open interest and funding for RKLB.